Financials in USD. Standardized financial statements.
A compact view of how Clover Health Investments, Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $672.89M | $462.27M | $281.02M |
| Revenue Growth? | +40.3% | +8.8% | +15.0% | -25.5% | +118.8% | +45.6% | +64.5% | 0.0% |
| Cost of Revenue? | $1.57B | $1.01B | $1.00B | $993.07M | $1.55B | $590.08M | $449.70M | $0 |
| Gross Profit? | $355.88M | $364.80M | $255.95M | $103.48M | -$79.18M | $82.81M | $12.56M | $281.02M |
| Gross Margin? | +18.5% | +26.6% | +20.3% | +9.4% | -5.4% | +12.3% | +2.7% | +100.0% |
| Operating Expenses? | $441.43M | $410.55M | $461.28M | $390.14M | $557.81M | $175.51M | $195.76M | $476.00M |
| Operating Income? | -$85.53M | -$45.75M | -$205.33M | -$286.66M | -$636.99M | -$92.71M | -$183.20M | -$185.80M |
| EBITDA? | -$83.86M | -$44.94M | -$207.63M | -$252.03M | -$569.60M | -$78.73M | -$324.12M | -$16.13M |
| Income Before Tax | -$85.55M | -$46.27M | -$210.15M | -$254.58M | -$587.76M | -$136.39M | -$363.74M | -$201.93M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$85.55M | -$43.01M | -$213.36M | -$339.57M | -$587.76M | -$136.39M | -$363.74M | -$201.93M |
| EPS? | $-0.17 | $-0.09 | $-0.45 | $-0.71 | $-1.25 | $-0.23 | $-0.90 | $-4.81 |
| Diluted EPS? | $-0.17 | $-0.09 | $-0.45 | $-0.71 | $-1.25 | $-0.23 | $-0.90 | $-4.81 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality